The therapeutic promise of positive allosteric modulation of nicotinic receptors

European Journal of Pharmacology

Volumn 727, Issue 1, 2014, Pages 181-185

  Uteshev, Victor V ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Analgesia; Cerebral ischemia; Choline; Nicotinic acetylcholine receptor; PNU 120596; Positive allosteric modulator

Indexed keywords

1 (5 CHLORO 2,4 DIMETHOXYPHENYL) 3 (5 METHYLISOXAZOL 3 YL)UREA; 3 (2,4 DIMETHOXYBENZYLIDENE)ANABASEINE; 3 [3 (PYRIDINE 3 YL) 1,2,4 OXADIAZOL 5 YL]BENZONITRILE; ACETYLCHOLINE; BUNGAROTOXIN RECEPTOR; CHOLINE; EPIBATIDINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA4BETA2; NS 9283; PNU 120596; TEBANICLINE; UNCLASSIFIED DRUG; ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; NEUROPROTECTIVE AGENT; NOOTROPIC AGENT;

ALLOSTERISM; ALZHEIMER DISEASE; ANALGESIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTICLE; AUTONOMIC DYSFUNCTION; AUTONOMIC NEUROPATHY; BODY TEMPERATURE; BRAIN ISCHEMIA; DEMENTIA; DRUG POTENCY; DRUG TARGETING; HEART RATE; HUMAN; INFLAMMATORY PAIN; NEUROPATHIC PAIN; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SCHIZOPHRENIA; TRAUMATIC BRAIN INJURY; VOMITING; ANIMAL; CENTRAL NERVOUS SYSTEM; DRUG DESIGN; DRUG EFFECTS; METABOLISM; MOLECULARLY TARGETED THERAPY; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION;

ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS; CENTRAL NERVOUS SYSTEM; DRUG DESIGN; HUMANS; MOLECULAR TARGETED THERAPY; NEUROPROTECTIVE AGENTS; NICOTINIC AGONISTS; NOOTROPIC AGENTS; RECEPTORS, NICOTINIC; SIGNAL TRANSDUCTION;

EID: 84898008848     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2014.01.072     Document Type: Article

References (72)

1. A. Akaike, Y. Takada-Takatori, T. Kume, and Y. Izumi Mechanisms of neuroprotective effects of nicotine and acetylcholinesterase inhibitors: role of alpha4 and alpha7 receptors in neuroprotection J. Mol. Neurosci. 40 2010 211 216
2. M. Alkondon, E.F. Pereira, W.S. Cortes, A. Maelicke, and E.X. Albuquerque Choline is a selective agonist of alpha7 nicotinic acetylcholine receptors in the rat brain neurons Eur. J. Neurosci. 9 1997 2734 2742 (Pubitemid 28082962)
3. G.W. Arendash, G.J. Sengstock, P.R. Sanberg, and W.R. Kem Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21 Brain Res. 674 1995 252 259
4. B. Badio, and J.W. Daly Epibatidine, a potent analgetic and nicotinic agonist Mol. Pharmacol. 45 1994 563 569 (Pubitemid 24139181)
5. R.T. Bartus, R.L. Dean 3rd, B. Beer, and A.S. Lippa The cholinergic hypothesis of geriatric memory dysfunction Science 217 1982 408 414
6. M. Bencherif, P.M. Lippiello, R. Lucas, and M.B. Marrero Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases Cell. Mol. Life Sci. 68 2011 931 949
7. S.M. Cabrera, C.M. Chavez, S.R. Corley, M.R. Kitto, and A.E. Butt Selective lesions of the nucleus basalis magnocellularis impair cognitive flexibility Behav. Neurosci. 120 2006 298 306 (Pubitemid 43807379)
8. P.M. Callahan, E.J. Hutchings, N.J. Kille, J.M. Chapman, and A.V. Terry Jr. Positive allosteric modulator of alpha 7 nicotinic-acetylcholine receptors, PNU-120596 augments the effects of donepezil on learning and memory in aged rodents and non-human primates Neuropharmacology 67 2013 201 212
9. M.I. Damaj, E.M. Meyer, and B.R. Martin The antinociceptive effects of alpha7 nicotinic agonists in an acute pain model Neuropharmacology 39 2000 2785 2791
10. L. Del Barrio, M.D. Martin-de-Saavedra, A. Romero, E. Parada, J. Egea, J. Avila, J.M. McIntosh, S. Wonnacott, and M.G. Lopez Neurotoxicity induced by okadaic acid in the human neuroblastoma SH-SY5Y line can be differentially prevented by alpha7 and beta2 nicotinic stimulation Toxicol. Sci. 123 2011 193 205
11. T. Dinklo, H. Shaban, J.W. Thuring, H. Lavreysen, K.E. Stevens, L. Zheng, C. Mackie, C. Grantham, I. Vandenberk, G. Meulders, L. Peeters, H. Verachtert, E. De Prins, and A.S. Lesage Characterization of 2-[[4-fluoro-3- (trifluoromethyl)phenyl]amino]-4-(4-pyridinyl)-5-thiazoleme thanol (JNJ-1930942), a novel positive allosteric modulator of the {alpha}7 nicotinic acetylcholine receptor J. Pharmacol. Exp. Ther. 336 2011 560 574
12. B. Djuricic, S.R. Olson, H.M. Assaf, T.S. Whittingham, W.D. Lust, and L.R. Drewes Formation of free choline in brain tissue during in vitro energy deprivation J. Cereb. Blood Flow Metab. 11 1991 308 313
13. J. Egea, A.O. Rosa, M. Sobrado, L. Gandia, M.G. Lopez, and A.G. Garcia Neuroprotection afforded by nicotine against oxygen and glucose deprivation in hippocampal slices is lost in alpha7 nicotinic receptor knockout mice Neuroscience 145 2007 866 872 (Pubitemid 46441652)
14. R. Faghih, S.M. Gopalakrishnan, J.H. Gronlien, J. Malysz, C.A. Briggs, C. Wetterstrand, H. Ween, M.P. Curtis, K.A. Sarris, G.A. Gfesser, R. El-Kouhen, H.M. Robb, R.J. Radek, K.C. Marsh, W.H. Bunnelle, and M. Gopalakrishnan Discovery of 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl) benzenesulfonami de (A-867744) as a novel positive allosteric modulator of the alpha7 nicotinic acetylcholine receptor J. Med. Chem. 52 2009 3377 3384
15. D. Feuerbach, K. Lingenhoehl, H.R. Olpe, A. Vassout, C. Gentsch, F. Chaperon, J. Nozulak, A. Enz, G. Bilbe, K. McAllister, and D. Hoyer The selective nicotinic acetylcholine receptor alpha7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and pain Neuropharmacology 56 2009 254 263
16. R. Freedman, M. Hall, L.E. Adler, and S. Leonard Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia Biol. Psychiatry 38 1995 22 33
17. R. Freedman, A. Olincy, R.W. Buchanan, J.G. Harris, J.M. Gold, L. Johnson, D. Allensworth, A. Guzman-Bonilla, B. Clement, M.P. Ball, J. Kutnick, V. Pender, L.F. Martin, K.E. Stevens, B.D. Wagner, G.O. Zerbe, F. Soti, and W.R. Kem Initial phase 2 trial of a nicotinic agonist in schizophrenia Am. J. Psychiatry 165 2008 1040 1047
18. K. Freitas, F.I. Carroll, and M.I. Damaj The antinociceptive effects of nicotinic receptors alpha7-positive allosteric modulators in murine acute and tonic pain models J. Pharmacol. Exp. Ther. 344 2012 264 275
19. K. Freitas, S.S. Negus, F.I. Carroll, and M.I. Damaj In vivo pharmacological interactions between a type II positive allosteric modulator of alpha7 nicotinic ACh receptors and nicotinic agonists in a murine tonic pain model Br. J. Pharmacol. 169 2013 567 579
20. T. Gasull, N. DeGregorio-Rocasolano, A. Zapata, and R. Trullas Choline release and inhibition of phosphatidylcholine synthesis precede excitotoxic neuronal death but not neurotoxicity induced by serum deprivation J. Biol. Chem. 275 2000 18350 18357 (Pubitemid 30414791)
21. V. Gerzanich, X. Peng, F. Wang, G. Wells, R. Anand, S. Fletcher, and J. Lindstrom Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors Mol. Pharm. 48 1995 774 782
22. Z.Z. Guan, X. Zhang, R. Ravid, and A. Nordberg Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease J. Neurochem. 74 2000 237 243 (Pubitemid 30012774)
23. A.G. Gusev, and V.V. Uteshev Physiological concentrations of choline activate native alpha7-containing nicotinic acetylcholine receptors in the presence of PNU-120596 [1-(5-chloro-2,4-dimethoxyphenyl)-3-(5-methylisoxazol-3- yl)-urea] J. Pharmacol. Exp. Ther. 332 2010 588 598
24. M.V. Guseva, D.M. Hopkins, S.W. Scheff, and J.R. Pauly Dietary choline supplementation improves behavioral, histological, and neurochemical outcomes in a rat model of traumatic brain injury J. Neurotrauma 25 2008 975 983
25. J.G. Harris, S. Kongs, D. Allensworth, L. Martin, J. Tregellas, B. Sullivan, G. Zerbe, and R. Freedman Effects of nicotine on cognitive deficits in schizophrenia Neuropsychopharmacology 29 2004 1378 1385 (Pubitemid 38780661)
26. M. Hu, M. Gopalakrishnan, and J. Li Positive allosteric modulation of alpha7 neuronal nicotinic acetylcholine receptors: lack of cytotoxicity in PC12 cells and rat primary cortical neurons Br. J. Pharmacol. 158 2009 1857 1864
27. R.S. Hurst, M. Hajos, M. Raggenbass, T.M. Wall, N.R. Higdon, J.A. Lawson, K.L. Rutherford-Root, M.B. Berkenpas, W.E. Hoffmann, D.W. Piotrowski, V.E. Groppi, G. Allaman, R. Ogier, S. Bertrand, D. Bertrand, and S.P. Arneric A novel positive allosteric modulator of the alpha7 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterization J. Neurosci. 25 2005 4396 4405 (Pubitemid 40628784)
28. D.S. Janowsky, M.K. el-Yousef, and J.M. Davis Acetylcholine and depression Psychosom. Med. 36 1974 248 257
29. B.I. Kalappa, A.G. Gusev, and V.V. Uteshev Activation of functional alpha7-containing nAChRs in hippocampal CA1 pyramidal neurons by physiological levels of choline in the presence of PNU-120596 PloS one 5 2010 e13964
30. B.I. Kalappa, F. Sun, S.R. Johnson, K. Jin, and V.V. Uteshev A positive allosteric modulator of alpha7 nAChRs augments neuroprotective effects of endogenous nicotinic agonists in cerebral ischaemia Br. J. Pharmacol. 169 2013 1862 1878
31. B.I. Kalappa, and V.V. Uteshev The dual effect of PNU-120596 on alpha7 nicotinic acetylcholine receptor channels Eur. J. Pharmacol. 718 2013 226 234
32. S. Kaneko, T. Maeda, T. Kume, H. Kochiyama, A. Akaike, S. Shimohama, and J. Kimura Nicotine protects cultured cortical neurons against glutamate-induced cytotoxicity via alpha7-neuronal receptors and neuronal CNS receptors Brain Res. 765 1997 135 140 (Pubitemid 27374924)
33. M.L. Kelso, and J.H. Oestreich Traumatic brain injury: central and peripheral role of alpha7 nicotinic acetylcholine receptors Curr. Drug Targets 13 2012 631 636
34. W.R. Kem The brain alpha7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease: studies with DMXBA (GTS-21) Behav. Brain Res. 113 2000 169 181 (Pubitemid 30645554)
35. C. Kiewert, A. Mdzinarishvili, J. Hartmann, U. Bickel, and J. Klein Metabolic and transmitter changes in core and penumbra after middle cerebral artery occlusion in mice Brain Res. 1312 2010 101 107
36. H. Kitagawa, T. Takenouchi, R. Azuma, K.A. Wesnes, W.G. Kramer, D.E. Clody, and A.L. Burnett Safety, pharmacokinetics, and effects on cognitive function of multiple doses of GTS-21 in healthy, male volunteers Neuropsychopharmacology 28 2003 542 551
37. C.H. Lee, C. Zhu, J. Malysz, T. Campbell, T. Shaughnessy, P. Honore, J. Polakowski, and M. Gopalakrishnan Alpha4beta2 neuronal nicotinic receptor positive allosteric modulation: an approach for improving the therapeutic index of alpha4beta2 nAChR agonists in pain Biochem. Pharmacol. 82 2011 959 966
38. B. Lendvai, F. Kassai, A. Szajli, and Z. Nemethy Alpha7 nicotinic acetylcholine receptors and their role in cognition Brain Res. Bull. 93 2013 86 96
39. S. Leonard, C. Breese, C. Adams, K. Benhammou, J. Gault, K. Stevens, M. Lee, L. Adler, A. Olincy, R. Ross, and R. Freedman Smoking and schizophrenia: abnormal nicotinic receptor expression Eur. J. Pharmacol. 393 2000 237 242 (Pubitemid 30193422)
40. E.D. Levin, F.J. McClernon, and A.H. Rezvani Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization Psychopharmacology (Berl) 184 2006 523 539 (Pubitemid 43255869)
41. Y. Li, R.L. Papke, Y.J. He, W.J. Millard, and E.M. Meyer Characterization of the neuroprotective and toxic effects of alpha7 nicotinic receptor activation in PC12 cells Brain Res. 830 1999 218 225 (Pubitemid 29297949)
42. S.L. McLean, N.F. Idris, B. Grayson, D.F. Gendle, C. Mackie, A.S. Lesage, D.J. Pemberton, and J.C. Neill PNU-120596, a positive allosteric modulator of alpha7 nicotinic acetylcholine receptors, reverses a sub-chronic phencyclidine-induced cognitive deficit in the attentional set-shifting task in female rats J. Psychopharmacol. 26 2012 1265 1270
43. S.J. Medhurst, J.P. Hatcher, C.J. Hille, S. Bingham, N.M. Clayton, A. Billinton, and I.P. Chessell Activation of the alpha7-nicotinic acetylcholine receptor reverses complete freund adjuvant-induced mechanical hyperalgesia in the rat via a central site of action J. Pain 9 2008 580 587
44. G. Munro, R. Hansen, H. Erichsen, D. Timmermann, J. Christensen, and H. Hansen The alpha7 nicotinic ACh receptor agonist compound B and positive allosteric modulator PNU-120596 both alleviate inflammatory hyperalgesia and cytokine release in the rat Br. J. Pharmacol. 167 2012 421 435
45. P.A. Newhouse, A. Potter, and A. Singh Effects of nicotinic stimulation on cognitive performance Curr. Opin. Pharmacol. 4 2004 36 46 (Pubitemid 38145836)
46. H.J. Ng, E.R. Whittemore, M.B. Tran, D.J. Hogenkamp, R.S. Broide, T.B. Johnstone, L. Zheng, K.E. Stevens, and K.W. Gee Nootropic alpha7 nicotinic receptor allosteric modulator derived from GABAA receptor modulators Proc. Natl. Acad.Sci. U.S.A. 104 2007 8059 8064 (Pubitemid 47185875)
47. R. Nirogi, V. Goura, R. Abraham, and P. Jayarajan Alpha4beta2 neuronal nicotinic receptor ligands (agonist, partial agonist and positive allosteric modulators) as therapeutic prospects for pain Eur. J. Pharmacol. 712 2013 22 29
48. A. Nordberg, and B. Winblad Reduced number of [3H]nicotine and [3H]acetylcholine binding sites in the frontal cortex of Alzheimer brains Neurosci. Lett. 72 1986 115 119 (Pubitemid 17184928)
49. A. Olincy, J.G. Harris, L.L. Johnson, V. Pender, S. Kongs, D. Allensworth, J. Ellis, G.O. Zerbe, S. Leonard, K.E. Stevens, J.O. Stevens, L. Martin, L.E. Adler, F. Soti, W.R. Kem, and R. Freedman Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia Arch. Gen. Psychiatry 63 2006 630 638 (Pubitemid 43848294)
50. R.L. Papke, M. Bencherif, and P. Lippiello An evaluation of neuronal nicotinic acetylcholine receptor activation by quaternary nitrogen compounds indicates that choline is selective for the alpha 7 subtype Neurosci. Lett. 213 1996 201 204 (Pubitemid 26264379)
51. R.L. Papke, and J.K.P. Papke Comparative pharmacology of rat and human alpha7 nAChR conducted with net charge analysis Br. J.Pharmacol. 137 2002 49 61 (Pubitemid 34983463)
52. E. Parada, J. Egea, I. Buendia, P. Negredo, A.C. Cunha, S. Cardoso, M.P. Soares, and M.G. Lopez The microglial alpha7-acetylcholine nicotinic receptor is a key element in promoting neuroprotection by inducing heme oxygenase-1 via nuclear factor erythroid-2-related factor 2 Antioxid. Redox Signal. 2013
53. E.K. Perry, C.M. Morris, J.A. Court, A. Cheng, A.F. Fairbairn, I.G. McKeith, D. Irving, A. Brown, and R.H. Perry Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology Neuroscience 64 1995 385 395
54. R.C. Petersen Scopolamine induced learning failures in man Psychopharmacology (Berl) 52 1977 283 289 (Pubitemid 8097255)
55. C. Qian, T. Li, T.Y. Shen, L.L. Garahan, J. Eckman, T. Biftu, and S. Ip Epibatidine is a nicotinic analgesic Eur. J. Pharmacol. 250 1993 13 14
56. A.M. Rao, J.F. Hatcher, and R.J. Dempsey Lipid alterations in transient forebrain ischemia: possible new mechanisms of CDP-choline neuroprotection J. Neurochem. 75 2000 2528 2535
57. F. Rode, G. Munro, D. Holst, E.O. Nielsen, K.B. Troelsen, D.B. Timmermann, L.C. Ronn, and M. Grunnet Positive allosteric modulation of alpha4beta2 nAChR agonist induced behaviour Brain Res. 1458 2012 67 75
58. R. Roncarati, C. Scali, T.A. Comery, S.M. Grauer, S. Aschmi, H. Bothmann, B. Jow, D. Kowal, M. Gianfriddo, C. Kelley, U. Zanelli, C. Ghiron, S. Haydar, J. Dunlop, and G.C. Terstappen Procognitive and neuroprotective activity of a novel alpha7 nicotinic acetylcholine receptor agonist for treatment of neurodegenerative and cognitive disorders J. Pharmacol. Exp. Ther. 329 2009 459 468
59. M.C. Rowbotham, W.R. Duan, J. Thomas, W. Nothaft, and M.M. Backonja A randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of ABT-594 in patients with diabetic peripheral neuropathic pain Pain 146 2009 245 252
60. S. Shimohama Nicotinic receptor-mediated neuroprotection in neurodegenerative disease models Biol. Pharm. Bull. 32 2009 332 336
61. S. Shimohama, D.L. Greenwald, D.H. Shafron, A. Akaike, T. Maeda, S. Kaneko, J. Kimura, C.E. Simpkins, A.L. Day, and E.M. Meyer Nicotinic à7 receptors protect against glutamate neurotoxicity and neuronal ischemic damage Brain Res. 779 1998 359 363 (Pubitemid 28039980)
62. F. Sun, K. Jin, and V.V. Uteshev A type-II positive allosteric modulator of alpha7 nAChRs reduces brain injury and improves neurological function after focal cerebral ischemia in rats PloS one 8 2013 e73581
63. H. Takeuchi, T. Yanagida, M. Inden, K. Takata, Y. Kitamura, K. Yamakawa, H. Sawada, Y. Izumi, N. Yamamoto, T. Kihara, K. Uemura, H. Inoue, T. Taniguchi, A. Akaike, R. Takahashi, and S. Shimohama Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone-induced Parkinson's disease models J. Neurosci. Res. 87 2009 576 585
64. M.S. Thomsen, M. El-Sayed, and J.D. Mikkelsen Differential immediate and sustained memory enhancing effects of alpha7 nicotinic receptor agonists and allosteric modulators in rats PloS one 6 2011 e27014
65. I.C. Umana, C.A. Daniele, and D.S. McGehee Neuronal nicotinic receptors as analgesic targets: it's a winding road Biochem. Pharmacol. 86 2013 1208 1214
66. V.V. Uteshev, E.M. Meyer, and R.L. Papke Regulation of neuronal function by choline and 4OH-GTS-21 through alpha 7 nicotinic receptors J. Neurophysiol. 89 2003 1797 1806 (Pubitemid 36444236)
67. S.L. Verbois, D.M. Hopkins, S.W. Scheff, and J.R. Pauly Chronic intermittent nicotine administration attenuates traumatic brain injury-induced cognitive dysfunction Neuroscience 119 2003 1199 1208 (Pubitemid 36776464)
68. T.L. Wallace, and R.H. Porter Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease Biochem. Pharmacol. 82 2011 891 903
69. H. Wang, M. Yu, M. Ochani, C.A. Amella, M. Tanovic, S. Susarla, J.H. Li, H. Yang, L. Ulloa, Y. Al-Abed, C.J. Czura, and K.J. Tracey Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation Nature 421 2003 384 388 (Pubitemid 36157937)
70. S.H. White, C.D. Brisson, and R.D. Andrew Examining protection from anoxic depolarization by the drugs dibucaine and carbetapentane using whole cell recording from CA1 neurons J. Neurophysiol. 107 2012 2083 2095
71. J.S. Yang, S.W. Seo, S. Jang, G.Y. Jung, and S. Kim Rational engineering of enzyme allosteric regulation through sequence evolution analysis PLoS Comput. Biol. 8 2012 e1002612
72. C.Z. Zhu, C.L. Chin, N.R. Rustay, C. Zhong, J. Mikusa, P. Chandran, A. Salyers, E. Gomez, G. Simler, L.G. Lewis, D. Gauvin, S. Baker, M. Pai, A. Tovcimak, J. Brown, V. Komater, G.B. Fox, M.W. Decker, P.B. Jacobson, M. Gopalakrishnan, C.H. Lee, and P. Honore Potentiation of analgesic efficacy but not side effects: co-administration of an alpha4beta2 neuronal nicotinic acetylcholine receptor agonist and its positive allosteric modulator in experimental models of pain in rats Biochem. Pharmacol. 82 2011 967 976